Table 2 Factors influencing risk of hospitalized HS patients’ death analyzed by univariate analysis.

From: Elevated platelet count is associated with decreased mortality from hemorrhagic stroke in hospital: a multi-center retrospective cohort study

 

Statistics

OR (95% CI)

P-value

Sex

Male, n (%)

1722 (52.79)

1.0

 

Female, n (%)

1540 (47.21)

0.95 (0.78, 1.17)

0.6417

Age (years)

67.05 ± 14.89

1.01 (1.01, 1.02)

 < 0.0001

Ethnicity

African-American, n (%)

406 (12.50)

1.0

 

Asian, n (%)

63 (1.94)

1.06 (0.50, 2.28)

0.8737

Caucasian, n (%)

2434 (74.92)

0.99 (0.73, 1.35)

0.9691

Hispanic, n (%)

156 (4.80)

1.05 (0.61, 1.79)

0.8638

Native American, n (%)

13 (0.40)

0.00 (0.00, inf.)

0.9586

Unknown, n (%)

177 (5.45)

1.25 (0.77, 2.04)

0.3704

BMI (kg/m 2)

27.79 ± 8.73

1.00 (0.99, 1.01)

0.7202

HBG (g/L)

12.80 ± 2.26

0.93 (0.89, 0.97)

0.0016

BUN (mmol/L)

21.47 ± 15.30

1.02 (1.01, 1.02)

 < 0.0001

PC (× 109/L)

221.67 ± 73.78

0.98 (0.97, 0.99)

0.0028

RBC (× 1012/L)

4.27 ± 0.74

0.81 (0.71, 0.93)

0.0500

ACS, n (%)

140 (4.29

2.02 (1.35, 3.03)

0.0006

CHF, n (%)

167 (5.12)

1.66 (1.13, 2.46)

0.0106

COPD, n (%)

119 (3.65)

1.29 (0.79, 2.11)

0.3119

Diabetes, n (%)

402 (12.32)

1.63 (1.24, 2.14)

0.0004

Cancer, n (%)

22 (0.67)

1.41 (0.47, 4.18)

0.5387

Hypertension, n (%)

1016 (31.15)

1.11 (0.90, 1.38)

0.3175

GIB, n (%)

21 (0.64)

0.32 (0.04, 2.36)

0.2606

Sepsis, n (%)

175 (5.36)

2.47 (1.74, 3.51)

 < 0.0001

Antiplatelet, n (%)

168 (5.15)

1.11 (0.72, 1.72)

0.6399

Anticoagulant, n (%)

54 (1.66)

0.94 (0.42, 2.09)

0.8784

Use cephalosporin

116 (3.56)

1.33 (0.81, 2.18)

0.2561

Back to article page